Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy最新文献

筛选
英文 中文
Trained Innate Immunity in Extracorporeal Photopheresis. 体外光再生训练先天免疫。
IF 1.2
Yandy Marx Castillo-Aleman
{"title":"Trained Innate Immunity in Extracorporeal Photopheresis.","authors":"Yandy Marx Castillo-Aleman","doi":"10.1111/1744-9987.70057","DOIUrl":"10.1111/1744-9987.70057","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"933-934"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Immune Response to COVID-19 Vaccines in Dialysis and Transplant Patients. 透析和移植患者对COVID-19疫苗的免疫反应
IF 1.2
Hui Wen You, Soo Kun Lim, Boon Hong Kong, Shian Feng Cheng, Reena Rajasuriar, Hui Wei You
{"title":"Exploring the Immune Response to COVID-19 Vaccines in Dialysis and Transplant Patients.","authors":"Hui Wen You, Soo Kun Lim, Boon Hong Kong, Shian Feng Cheng, Reena Rajasuriar, Hui Wei You","doi":"10.1111/1744-9987.70066","DOIUrl":"10.1111/1744-9987.70066","url":null,"abstract":"<p><strong>Introduction: </strong>This study explores immune responses to SARS-CoV-2 vaccination among dialysis patients and kidney transplant recipients (KTRs). Dialysis patients and KTRs often exhibit lower seroconversion rates, particularly the latter, due to immunosuppressive therapies.</p><p><strong>Methods: </strong>The prospective study was conducted at the University Malaya Medical Centre (UMMC), involving 62 dialysis patients and 49 KTRs.</p><p><strong>Results: </strong>Dialysis patients exhibited high seroconversion (97.8%) and T-cell response (77.4%). In contrast, KTRs had poor seroconversion (59.2%) and a weak T-cell response (44.9%) after a third dose. Furthermore, 32.7% of KTRs were non-reactive in both antibody and T-cell responses. A moderate correlation was found between antibody levels and T-cell responses in KTRs (p = 0.033, r = 0.305). Among dialysis patients, lower BMI was significantly associated with reduced seroconversion, while longer dialysis duration and the presence of hypertension were positively associated with antibody response. Other clinical factors, including age, gender, diabetes, and prior COVID-19 infection, showed no significant association.</p><p><strong>Conclusion: </strong>The findings suggest dialysis patients respond better to vaccination, while KTRs experience impaired immune responses. Within dialysis patients, BMI, dialysis duration, and hypertension influenced antibody response. Monitoring post-vaccination immune responses in KTRs may help identify non-responders, who could benefit from alternative vaccination strategies or adjustments in immunosuppressive therapy. This study was approved by the University Malaya Medical Centre Medical Research Ethics Committee (UMMC-MREC), Approval No: 202131-9888.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"839-849"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144628466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the performance of chat generative pretrained transformer (ChatGPT) in answering chronic kidney disease-related questions. 评估聊天生成预训练转换器(ChatGPT)在回答慢性肾脏疾病相关问题中的性能。
IF 1.2
Başak Can, Esra Deniz Kahvecioğlu, Fatih Palıt, Egemen Cebeci, Mehmet Küçük, Zeynep Karaali
{"title":"Assessing the performance of chat generative pretrained transformer (ChatGPT) in answering chronic kidney disease-related questions.","authors":"Başak Can, Esra Deniz Kahvecioğlu, Fatih Palıt, Egemen Cebeci, Mehmet Küçük, Zeynep Karaali","doi":"10.1111/1744-9987.14239","DOIUrl":"10.1111/1744-9987.14239","url":null,"abstract":"<p><strong>Background: </strong>Chatbots produced by artificial intelligence are frequently used in health information today. We aimed to investigate the reliability and reproducibility of the answers given by Chat Generative Pretrained Transformer (ChatGPT), one of the most used chatbots, to frequently asked questions related to chronic kidney failure.</p><p><strong>Methods: </strong>We reviewed frequently asked questions related to chronic kidney disease (CKD) from social media platforms and Internet. The questions were asked to ChatGPT, and the answers were scored from 1 to 4 by two experienced nephrologists.</p><p><strong>Results: </strong>Eighty-five frequently asked questions about chronic renal failure were examined and 60 of them were included in the study after exclusion criteria. Fifty-one (85%) of the questions received 1 point, 7 (11.7%) received 2 points and 2 (3.3%) received 3 points. The similarity rates of the answers to the repeated questions were between 80% and 100%.</p><p><strong>Conclusion: </strong>ChatGPT has provided reliable responses with high reproducibility to inquiries related to CKD.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"760-765"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142840708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective Evaluation of Continuous Plasma Exchange With Dialysis With Suspected Thrombotic Microangiopathy in Intensive Care Unit. 重症监护病房疑似血栓性微血管病变患者持续血浆置换透析的前瞻性评价。
IF 1.2
Kasumi Satoh, Manabu Okuyama, Hajime Nakae
{"title":"Prospective Evaluation of Continuous Plasma Exchange With Dialysis With Suspected Thrombotic Microangiopathy in Intensive Care Unit.","authors":"Kasumi Satoh, Manabu Okuyama, Hajime Nakae","doi":"10.1111/1744-9987.70039","DOIUrl":"10.1111/1744-9987.70039","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"802-803"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144029427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunoabsorption Therapy for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Retrospective Study. 髓鞘少突胶质细胞糖蛋白抗体相关疾病的免疫吸收治疗:一项回顾性研究
IF 1.2
Dongxue Wang, Yunjin Xiong, Jing Liu, Yiduo Feng, Changqin Zhang, Yin Zhang, Xia Ding, Xiaoyuan Wu, Akehu Alemasi, Qi Huang, Yu Wu, Huabing Wang, Yong Gong, De-Cai Tian, Yilun Zhou
{"title":"Immunoabsorption Therapy for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Retrospective Study.","authors":"Dongxue Wang, Yunjin Xiong, Jing Liu, Yiduo Feng, Changqin Zhang, Yin Zhang, Xia Ding, Xiaoyuan Wu, Akehu Alemasi, Qi Huang, Yu Wu, Huabing Wang, Yong Gong, De-Cai Tian, Yilun Zhou","doi":"10.1111/1744-9987.70063","DOIUrl":"10.1111/1744-9987.70063","url":null,"abstract":"<p><strong>Introduction: </strong>The elimination of myelin oligodendrocyte glycoprotein (MOG) antibodies using immunoadsorption (IA) is a therapeutic approach, but has not yet been specifically evaluated in MOG antibody-associated disease (MOGAD). This study aimed to provide evidence on the efficacy and safety of IA therapy for MOGAD.</p><p><strong>Methods: </strong>This retrospective study included patients diagnosed with MOGAD, who were treated with IA. Clinical data of the patients were collected. The extended disability score scale (EDSS) before and after IA therapy was used to evaluate neurological status.</p><p><strong>Results: </strong>Six patients aged 14-53 years were enrolled in this study. Each patient received 3-7 sessions of IA therapy. Half of the patients showed significant clinical improvement after IA, with EDSS scores decreasing by more than 1.0, whereas the other patients were unresponsive to IA. Partial remission of visual acuity was obtained in three of the four patients with visual impairment. Repeated detection of MOG antibodies in one case showed that the titer declined from 1:100 to 1:32 after five sessions of IA. Only one episode of mild hypotension was observed in 29 IA sessions.</p><p><strong>Conclusion: </strong>IA therapy may be a potential treatment option for patients with MOGAD.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"776-781"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144586032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abbreviation usage in nephrology: A nephrologist's perspective. 肾病学中的缩写用法:肾病专家的观点。
IF 1.2
Chia-Ter Chao
{"title":"Abbreviation usage in nephrology: A nephrologist's perspective.","authors":"Chia-Ter Chao","doi":"10.1111/1744-9987.70033","DOIUrl":"10.1111/1744-9987.70033","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"808-809"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparative Assessment of Large Language Models in Pediatric Dialysis: Reliability, Quality and Readability. 儿童透析大语言模型的比较评估:可靠性、质量和可读性。
IF 1.2
Esra Ensari, Esra Nagehan Akyol Onder, Pelin Ertan
{"title":"A Comparative Assessment of Large Language Models in Pediatric Dialysis: Reliability, Quality and Readability.","authors":"Esra Ensari, Esra Nagehan Akyol Onder, Pelin Ertan","doi":"10.1111/1744-9987.70058","DOIUrl":"10.1111/1744-9987.70058","url":null,"abstract":"<p><strong>Introduction: </strong>This study evaluated the reliability, quality, and readability of ChatGPT (OpenAI, San Francisco, CA), Gemini (Google, Mountain View, CA), and Copilot (Microsoft Corp., Washington, DC) which are among the most widely used large language models (LLMs) today in answering frequently asked questions (FAQs) related to pediatric dialysis.</p><p><strong>Methods: </strong>A total of 45 FAQs were entered into LLM. The Modified DISCERN (mDISCERN) scale assessed reliability; the Global Quality Score (GQS) evaluated quality; and readability was assessed using five metrics: Coleman-Liau Index (CLI), Simple Measure of Gobbledygook (SMOG), Gunning Fog Index (GFI), Flesch Reading Ease (FRE) and Flesch-Kincaid Grade Level (FKGL). Questions were directed to the chat robots twice, on January 25, 2025, and February 1, 2025.</p><p><strong>Results: </strong>All three chatbots displayed high reliability, achieving median mDISCERN scores of 5. Quality scores on the GQS were similarly high, with median scores of 5 across platforms; however, Gemini exhibited greater variability (range 1-5) compared to ChatGPT-4o and Copilot (ranges 3-5). Readability scores revealed that chatbot responses were written at an advanced level.</p><p><strong>Conclusion: </strong>This study found that LLMs responses to dialysis FAQs were reliable and high quality, but difficult to read; improving readability through expert-reviewed content could increase their impact on public health.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"739-746"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-to-high-density lipoprotein ratio with diabetic nephropathy". 《中性粒细胞-淋巴细胞比值、血小板-淋巴细胞比值、单核细胞-高密度脂蛋白比值与糖尿病肾病的关系》一文评论。
IF 1.2
Mostafa Javanian, Mohammad Barary, Soheil Ebrahimpour
{"title":"Commentary on \"Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-to-high-density lipoprotein ratio with diabetic nephropathy\".","authors":"Mostafa Javanian, Mohammad Barary, Soheil Ebrahimpour","doi":"10.1111/1744-9987.70030","DOIUrl":"10.1111/1744-9987.70030","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"806-807"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasmapheresis as rescue therapy for steroid-resistant isolated optic neuritis: A case report. 血浆置换作为类固醇抵抗性孤立性视神经炎的抢救治疗:1例报告。
IF 1.2
Eiman Abdel Wahab Fayez Hussein, Mohamed Hussein
{"title":"Plasmapheresis as rescue therapy for steroid-resistant isolated optic neuritis: A case report.","authors":"Eiman Abdel Wahab Fayez Hussein, Mohamed Hussein","doi":"10.1111/1744-9987.70034","DOIUrl":"10.1111/1744-9987.70034","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"800-801"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144062351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Arteriovenous Fistula Creation on GFR Decline. 动静脉造瘘对GFR下降的影响。
IF 1.2
Beyza Doğan, Fatih Ergül, Mikail Dağ, Süleyman Karaköse, İbrahim Güney
{"title":"The Effect of Arteriovenous Fistula Creation on GFR Decline.","authors":"Beyza Doğan, Fatih Ergül, Mikail Dağ, Süleyman Karaköse, İbrahim Güney","doi":"10.1111/1744-9987.70054","DOIUrl":"10.1111/1744-9987.70054","url":null,"abstract":"<p><strong>Purpose: </strong>Chronic kidney disease (CKD) poses a significant public health challenge, severely affecting patients' quality of life. The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend discussing renal replacement therapy options when patients reach CKD stage 4. Arteriovenous fistula (AVF) creation is considered the gold standard for vascular access in hemodialysis. This retrospective study aims to evaluate whether any changes in kidney function occur during the follow-up period after AVF creation in patients with end-stage kidney disease (ESKD).</p><p><strong>Methods: </strong>We analyzed data from 60 CKD patients who underwent AVF creation and were monitored in our nephrology outpatient clinics. Seventeen patients who consistently attended follow-up visits were included for detailed analysis. We performed a retrospective review of laboratory and medical records from 6 months before and 6 months following AVF creation.</p><p><strong>Results: </strong>The cohort comprised 41.2% males, with a mean age of 62.4 years. The predominant underlying conditions were diabetes mellitus (58.8%), hypertension (29.4%), and polycystic kidney disease (11.8%). Statistical analysis of laboratory values before and after AVF creation (at 1, 3, and 6 months) revealed a significant decline in estimated glomerular filtration rate (eGFR) before AVF placement, followed by stabilization in the subsequent 6 months.</p><p><strong>Conclusion: </strong>The rate of eGFR decline was significantly reduced in CKD patients with AVF. This may be attributed to increased awareness of impending hemodialysis, leading to better dietary adherence and treatment compliance.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"747-751"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144287644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书